Sergio Piomelli

Q: What Schools Are Affiliated With Sergio Piomelli

Sergio Piomelli is affiliated with the following schools: Columbia University, New York University

Sergio Piomelli's AcademicInfluence.com Rankings

Sergio Piomelli

Medical

#3474

World Rank

#3943

Historical Rank

Pharmacology

#439

World Rank

#493

Historical Rank

medical Degrees

Sergio Piomelli

Philosophy

#9946

World Rank

#13578

Historical Rank

Logic

#6897

World Rank

#8455

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Sergio Piomelli's Degrees

PhD Pharmacology University of California, Irvine
Doctorate Medicine University of California, Irvine

Why Is Sergio Piomelli Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Sergio Piomelli's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Preventing lead poisoning in young children (1978) (881)
A micromethod for free erythrocyte porphyrins: the FEP test. (1973) (373)
Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results. (2006) (267)
Separation of erythrocytes according to age on a simplified density gradient. (1974) (247)
In vivo lability of glucose-6-phosphate dehydrogenase in GdA- and GdMediterranean deficiency. (1968) (177)
The mechanism of red cell aging. I. Relationship between cell age and specific gravity evaluated by ultracentrifugation in a discontinuous density gradient. (1967) (170)
Transcranial Doppler measurements of the middle cerebral artery. Effect of hematocrit. (1988) (170)
Population genetics of haemoglobin variants, thalassaemia and glucose-6-phosphate dehydrogenase deficiency, with particular reference to the malaria hypothesis. (1966) (155)
Brain infarction in sickle cell anemia: Magnetic resonance imaging correlates (1988) (147)
Cerebral hyperemia, stroke, and transfusion in sickle cell disease (1989) (146)
Erythropoietic protoporphyria and lead intoxication: the molecular basis for difference in cutaneous photosensitivity. I. Different rates of disappearance of protoporphyrin from the erythrocytes, both in vivo and in vitro. (1975) (137)
Mechanism of red blood cell aging: Relationship of cell density and cell age (1993) (123)
Management of childhood lead poisoning. (1984) (121)
Threshold for lead damage to heme synthesis in urban children. (1982) (117)
Echocardiographic abnormalities in patients with transfusion-dependent anemia and secondary myocardial iron deposition. (1978) (115)
The decline in energetic metabolism with aging of the erythrocyte and its relationship to cell death (1980) (115)
The FEP (free erythrocyte porphyrins) test: a screening micromethod for lead poisoning. (1973) (113)
Erythropoietic protoporphyria and lead intoxication: the molecular basis for difference in cutaneous photosensitivity. II. Different binding of erythrocyte protoporphyrin to hemoglobin. (1975) (112)
Free erythrocyte porphyrins in the detection of undue absorption of Pb and of Fe deficiency. (1977) (110)
Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Childrens Cancer Group. (1994) (89)
Correlation of chromosome abnormalities with patient characteristics, histologic subtype, and induction success in children with acute nonlymphocytic leukemia. (1985) (89)
Complete suppression of the symptoms of congenital erythropoietic porphyria by long-term treatment with high-level transfusions. (1986) (85)
Blood lead concentrations in a remote Himalayan population. (1980) (81)
Erythrocyte adenosine deaminase deficiency without immunodeficiency. Evidence for an unstable mutant enzyme. (1979) (81)
Isozymes of human phosphofructokinase: identification and subunit structural characterization of a new system. (1980) (80)
PREVENTION OF BONE MALFORMATIONS AND CARDIOMEGALY IN COOLEY'S ANEMIA BY EARLY HYPERTRANSFUSION REGIMEN * (1969) (78)
Rapid diagnosis of iron deficiency by measurement of free erythrocyte porphyrins and hemoglobin: the FEP/hemoglobin ratio. (1976) (74)
HYPERTRANSFUSION REGIMEN IN PATIENTS WITH Cooley's ANEMIA * (1974) (64)
Regulation of glycolysis in the erythrocyte: role of the lactate/pyruvate and NAD/NADH ratios. (1991) (61)
Neurologic complications of sickle cell disease. (1989) (60)
Effects of Total Hemoglobin and Hemoglobin S Concentration on Cerebral Blood Flow During Transfusion Therapy to Prevent Stroke in Sickle Cell Disease (1994) (60)
Elevated AMP pyrophosphorylase activity in congenital IMP pyrophosphorylase deficiencey (Lesch-Nyhan disease). (1969) (58)
G6PD deficiency and chronic hemolysis: four new mutants--relationships between clinical syndrome and enzyme kinetics. (1971) (58)
Clinical and biochemical interactions of glucose-6-phosphate dehydrogenase deficiency and sickle-cell anemia. (1972) (56)
Middle Cerebral Artery Velocity Changes During Transfusion in Sickle Cell Anemia (1994) (53)
Survival of 51Cr‐Labelled Red Cells in Subjects with Thalassaemia‐Trait or G6PD Deficiency or Both Abnormalities (1964) (50)
Hydroxyurea in congenital erythropoietic porphyria. (1994) (49)
Chelation therapy in beta-thalassemia major. III. The role of splenectomy in achieving iron balance. (1981) (49)
Separation of younger red cells with improved survival in vivo: an approach to chronic transfusion therapy. (1978) (49)
Simultaneous quantitation of zinc protoporphyrin and free protoporphyrin in erythrocytes by acetone extraction. (1981) (49)
Preclinical abnormal segmental cardiac manifestations of thalassemia major in children on transfusion-chelation therapy: echographic alterations of left ventricular posterior wall contraction and relaxation patterns. (1982) (48)
Middle cerebral artery blood velocity and cerebral blood flow in sickle cell disease. (1991) (46)
The Haematological Effects of Glucose‐6‐Phosphate Dehydrogenase Deficiency and Thalassaemia Trait: Interaction between the Two Genes at the Phenotype Level (1969) (43)
Remission induction in children with acute non-lymphocytic leukemia using cytosine arabinoside and doxorubicin or daunorubicin: a report from the Childrens Cancer Study Group. (1989) (42)
Disparate enzyme activity in erythocytes and leukocytes. A variant of hypoxanthine phosphoribosyl-transferase deficiency with an unstable enzyme. (1973) (41)
The molecular mechanism of the inherited phosphofructokinase deficiency associated with hemolysis and myopathy. (1980) (41)
The management of patients with Cooley's anemia: transfusions and splenectomy. (1995) (37)
Childhood lead poisoning. (2002) (36)
Heart transplant in a factor VIII‐deficient patient with a high‐titre inhibitor: perioperative management using high‐dose continuous infusion factor VIII and recombinant factor VIIa (2001) (34)
Management of thalassemia major (Cooley's anemia). (1991) (33)
Cooley anemia: high transfusion regimen and chelation therapy, results, and perspective. (1978) (33)
Rapid Quantitative Assay for Erythrocyte Porphyrins: Rapid Quantitative Microfluorometric Assay Applicable to the Diagnosis of Erythropoietic Protoporphyria (1974) (32)
A novel mutation in erythropoietic protoporphyria: an aberrant ferrochelatase mRNA caused by exon skipping during RNA splicing. (1993) (31)
Rapid quantitative assay for erythrocyte porphyrins. (1974) (31)
The hemolytic anemia of magnesium deficiency in adult rats. (1973) (31)
A simple technique for preparation of young red cells for transfusion from ordinary blood units. (1982) (30)
CT in B-thalassemia: iron deposition in the liver, spleen, and lymph nodes. (1981) (29)
Failure to detect linkage between Xg and other X‐borne loci in Sardinians (1966) (29)
An isozyme of hexokinase specific for the human red blood cell (HKR) (1990) (29)
Identification of the cDNA for human red blood cell-specific hexokinase isozyme. (1997) (28)
Screening for ferrochelatase mutations: molecular heterogeneity of erythropoietic protoporphyria. (1994) (27)
Childhood lead poisoning in the '90s. (1994) (26)
Current Strategies in the Management of Cooley's Anemia a (1985) (26)
Lead‐Induced Abnormalities of Porphyrin Metabolism The Relationship with Iron Deficiency a (1987) (24)
MRI marrow observations in thalassemia: The effects of the primary disease, transfusional therapy, and chelation (2005) (24)
The synthesis of heme and globin in the maturing human erythroid cell. (1961) (23)
Chronic transfusions in patients with sickle cell disease. Indications and problems. (1985) (23)
Chelation therapy and cardiac status in older patients with thalassemia major. (1990) (22)
Serum transferrin receptor as a marker of erythropoiesis suppression in patients on chronic transfusion (1999) (21)
Supportive care for children with cancer. Guidelines of the Childrens Cancer Study Group. Use of venous access lines. (1984) (21)
Bone marrow transplantation for acute non-lymphocytic leukemia: a report from the Childrens Cancer Study Group of sixty-seven children transplanted in first remission. (1987) (21)
Systematic screening for RNA with skipped exons--splicing mutations of the ferrochelatase gene. (1995) (19)
Human HKR isozyme: organization of the hexokinase I gene, the erythroid-specific promoter, and transcription initiation site. (1999) (19)
Microcytic anemia with erythroblastosis in offspring of magnesium-deprived rats. (1970) (18)
Sickle cell diseases in the 1990s: the need for active and preventive intervention. (1991) (18)
Experience with 500 prenatal diagnoses of sickle cell diseases: The effect of gestational age on affected pregnancy outcome (1994) (18)
Expression of myeloid differentiation antigens in acute nonlymphocytic leukemia: increased concentration of CD33 antigen predicts poor outcome--a report from the Childrens Cancer Study Group. (1992) (18)
Chemical toxicity of red cells. (1981) (17)
CHELATION THERAPY, TRANSFUSION REQUIREMENT, AND IRON BALANCE IN YOUNG THALASSEMIC PATIENTS * (1980) (17)
Deferoxamine-induced platyspondyly in hypertransfused thalassemic patients (1995) (16)
CT imaging of splenic sequestration in sickle cell disease (2000) (16)
Bone marrow transplantation for thalassemia. (1987) (16)
MR marrow signs of iron overload in transfusion-dependent patients with sickle cell disease (2005) (15)
The mechanism of decline of age-dependent enzymes in the red blood cell. (1991) (15)
A novel splicing mutation in the ferrochelatase gene responsible for erythropoietic protoporphyria. (1994) (15)
The relationship of total red cell volume to total body water in octogenarian males. (1962) (14)
The diagnostic utility of measurements of erythrocyte porphyrins. (1987) (14)
Prevention of carryover contamination in the detection of βS and βC genes by polymerase chain reaction (1992) (14)
Antigenicity of human vascular endothelium: lack of relationship to the pathogenesis of vasculitis. (1959) (13)
HOW DO RED CELL ENZYMES AGE? HYPOTHESIS AND FACTS (1986) (13)
Erythropoietic protoporphyria: four novel frameshift mutations in the ferrochelatase gene. (1997) (13)
THE BIOCHEMICAL BASIS OF THE CLINICAL INTERACTION OF Fe DEFICIENCY AND Pb INTOXICATION (1984) (13)
Population genetics of haemoglobin variants thalassaemia and G6PD-deficiency with particular reference to the malaria hypothesis. (1967) (12)
Inappropriately low red cell 2,3-diphosphoglycerate and p50 in transfused beta-thalassemia. (1984) (12)
10 Management of Cooley's anaemia (1993) (12)
Hereditary hemolytic anemia due to enzyme defects of glycolysis. (1976) (12)
Management of Cooley's anaemia. (1993) (12)
Rapid prenatal diagnosis of sickle cell diseases using oligonucleotide ligation assay coupled with laser‐induced capillary fluorescence detection (2002) (12)
A possible case of alpha-beta thalassaemia. (1962) (11)
Antibody to varicella-zoster virus after passive immunization against chickenpox (1978) (10)
Oral iron chelators. (1990) (10)
Planning an exchange transfusion in patients with sickle cell syndromes. (1990) (10)
Cardiovascular adaptations to transfusion/chelation therapy of homozygote sickle cell anemia. (1988) (9)
Roentgenographic manifestations of pyruvate kinase deficiency hemolytic anemia. (1971) (8)
Disparate Enzyme Activity in Erythrocytes and Leukocytes (8)
Measurement of free erythrocyte protoporphyrin in blood collected on filter paper as a screening test to detect lead poisoning in children. (1976) (8)
Pulmonary embolism developing in patients with sickle cell disease on hypertransfusion and IV deferoxamine chelation therapy (1997) (7)
Bone marrow transplantation in sickle cell diseases: a plea for a rational approach. (1992) (7)
Laboratory parameters in patients randomized in the stop study and their modification by transfusion (2000) (7)
G6PD-RELATED NEONATAL JAUNDICE (1986) (7)
Laboratory diagnosis of lead poisoning. (1980) (7)
Red blood cell protoporphyrin accumulation in experimental lead poisoning. (1980) (7)
The Xga antigen on red cells and fibroblasts. (1978) (6)
Cystic fibrosis in a black child with hemoglobin S-D disease. (1990) (6)
SURVIVAL OF SKIN HOMOGRAFTS IN RADIATION CHIMERAS (1961) (6)
Recent advances in the management of thalassemia (1995) (5)
Cooley's anemia management: 25 years of progress. (1989) (5)
Neuropsychological consequences of sickle cell disease (1996) (5)
Oral Iron Chelators for the Clinical Management of Iron Overload (1990) (5)
Acute vascular purpura following immunization with Asiatic-influenza vaccine. (1958) (4)
An immune hemolytic anemia as a component of secondary disease in rabbit radiation chimeras. (1960) (4)
Prevention of carryover contamination in the detection of beta S and beta C genes by polymerase chain reaction. (1992) (3)
The mechanism of enzyme decline in the red blood cell during the "in vivo" aging process. (1991) (3)
Decay of mammalian hexokinase: characterization of the specific proteolytic activity. (1991) (3)
Human protoporphyria: genetic heterogeneity at the ferrochelatase locus (1995) (3)
376 THE THRESHOLD OF LEAD TOXICITY IN CHILDREN (1978) (3)
The Possible Role of Genetic Modifiers in the Clinical Severity of Sickle Cell Syndromes a (1989) (2)
Stroke prevention in sickle cell disease (stop): Final results (2000) (2)
RAPID DIAGNOSIS OF Fe DEFICIENCY BY MEASUREMENT OF FREE ERYTHROCYTE PORPHYRINS (FEP) (1974) (2)
Workshop Summaries: The Splenectomy Controversy (2005) (2)
Immuno-Hematologic Disorders in Childhood (1959) (2)
[Chronic intermittent thrombotic-thrombocytopenic purpura]. (1957) (2)
CHILDHOOD LEAD POISONING PREVENTION. AUTHORS' REPLY (1999) (2)
Diagnostic approaches to anemia. (1971) (1)
Acute Chest Syndrome Is Strongly Associated Parvo Virus B19 Seroconversion in Patients with Hemoglobin SC Disease. (2004) (1)
Osmotic fragility of erythrocytes: comparison of continuous recording and multiple tube methods. (1971) (1)
Bone marrow transplantation for acute non-lymphocytic leukemia (1987) (1)
The hazards of benign(?) neglect of elevated blood lead levels. (1987) (1)
Group meetings with parents of children with Cooley's anemia. (1978) (1)
Neonatal screening for glucose-6-phosphate dehydrogenase deficiency. (1992) (1)
[A new hemorrhagic syndrome in a newborn girl: associated deficiency of plasma thromboplastin, factor VII and prothrombin]. (1956) (1)
Attempts at experimental production of acute vascular (anaphylactoid) purpura. (1962) (1)
Measurement of radiolabeled lactate production using lactate monooxygenase. (1993) (1)
Reduction of iron overload in thalassemia. (1982) (1)
Filter-paper lead tests (1996) (1)
Clinical management of beta-thalassemia. (1980) (1)
937 INTERACTION OF PYRUVATE/LACTATE AND NAD/NADH RATIOS IN THE REGULATION OF RED CELL (RBC) GLYCOLYSIS (1985) (0)
ELEVATION OF δ -AMINOLEVULINIC ACID DEHYDRATASE (ALAD) AND ERYTHROCYTE PORPHYRINS (EP) IN SICKLE CELL SYNDROMES (1987) (0)
648 TRANSFUSION OF YOUNG RBCs WITH IMPROVED SURVIVAL: A NEW APPROACH TO THE THERAPY OF COOLEY'S ANEMIA (1978) (0)
GENERAL DISCUSSION:CLINICAL MANAGEMENT (1980) (0)
905 ASSOCIATION OF A PLATELET AGGREGATION DEFECT WITH HEPATOCELLULAR CARCINOMA (1985) (0)
[Research on the behavior of fibrinolysis factors in malignant and tuberculous adenopathies]. (1956) (0)
Index rerum ad Vol. 12 (1962) (0)
[Studies on viral entity of two ascitic tumors in mouse; sarcoma 37, Ehrlich ascites carcinoma]. (1957) (0)
Separation of Normoblasts from Whole Blood by Ultracentrifugation on Arabino‐Galactane Discontinuous Gradients: A Tool for Prenatal Diagnosis (2005) (0)
[Erythremoid reaction in the chicken caused by vaccination against Newcastle disease]. (1955) (0)
Book Reviews – Buchbesprechnungen – Livres Nouveaux (1962) (0)
CHILDHOOD LEAD POISONING PREVENTION: Piomelli and Schoenbrod re Needleman (1999) (0)
[Antibiotics and blood coagulation; in vitro and in vivo experiences]. (1956) (0)
Contents, Vol. 12, 1962 (1962) (0)
SEPARATION OF RBCs WITH IMPROVED SURVIVAL FROM NORMAL BLOOD (1974) (0)
A SIMPLE TECHNIQUE FOR ELETRONIC COUNTING AND SIZING PLATELETS (1977) (0)
[Hemophilia B; description of four cases in a family]. (1957) (0)
The isoenzymes of mammalian hexokinase: tissue specificity and in vivo decline. (1991) (0)
THE DETECTION OF SUBCLINICAL Pb INTOXICATION IN URBAN CHILDREN (1974) (0)
[Effects of reserpine on blood coagulation & fibrinolysis]. (1957) (0)
[Effect of lyzozyme on blood coagulation; in vitro and in vivo studies in normal persons]. (1956) (0)
The Molecular Basis of Different Hexokinase (HK) Defects; Two Isozymes (HKr and HK1) Produced from a Single Gene by Alternate Promoters ♦ 787 (1998) (0)
[Anticoagulant and fibrinolytic action of parenteral trypsin; experimental study]. (1956) (0)
Studies on homologous bone marrow transplantation in irradiated rabbits. (1961) (0)
Letters to the Editor (1973) (0)
HOW TO EXCHANGE TRANSFUSE PATIENTS WITH SICKLE CELL DISEASE (1984) (0)
A MORE ECONOMICAL AND EFFECTIVE BLOOD PRODUCT FOR CHRONIC TRANSFUSIONS (1987) (0)
THE INTERACTION OF IRON DEFICIENCY AND LEAD POISONING IN NORMAL CHILDREN. AN EPIDMIOLGICAL STUDY (1987) (0)
Failure to influence the rejection time to homologous skin grafts in the rabbit by prior injection of donor blood. (1961) (0)
[Use of lyophilized blood plasma fractions for the in vitro correction of the deficit of thromboplastin generation; observations induced from an observed hemorrhagic syndrome due to combined deficit of PTC, factor VII and prothrombin]. (1956) (0)
126 LEFT VENTRICULAR CONTRACTION-RELAXATION SEQUENCES IN THALASSEMIA MAJOR (1981) (0)
[Titration of antifibrinolytic power of the human blood; description of a new method]. (1956) (0)
THE BIOCHEMICAL EXPLANATION FOR LACK OF PHOTOSENSIT IVITY IN Pb INTOXICATION (1974) (0)
608 TIME SEQUENCE OF RBC PROTOPORPHYRIN (PP) ACCUMULATION IN LEAD POISONING (1978) (0)
Assessment of Erythropoiesis Suppression in Patients on Chronic Blood Transfusions: Value of Serum Transferrin Receptor, Erythropoietin and Reticulocytes † 803 (1998) (0)
Reason for Transfusion and CT / MRI Recurrent acute chest syndrome Recurrent acute chest syndrome Recurrent acute chest syndrome TIA Stroke : small pontine infarct Stroke : L caudate Irrfarct Stroke : L frontal and frontoparietal infarct Stroke (0)
[Panmyelopenia secondary to prolonged & intensive administration of bismuth preparations]. (1957) (0)
In Sickle Cell Disease Patients Coagulation Abnormalities Are Not A Major Predisposing Factor To Stroke † 768 (1998) (0)
Reply (1988) (0)
Book Review:Dietary and Environmental Lead: Human Health Effects. Kathryn R. Mahaffey (1986) (0)
Subject Index Vol. 22, 1978 (1978) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Sergio Piomelli?

Sergio Piomelli is affiliated with the following schools:

Sergio Piomelli's Academic­Influence.com Rankings

Sergio Piomelli's Degrees

Why Is Sergio Piomelli Influential?

Sergio Piomelli's Published Works

Published Works

What Schools Are Affiliated With Sergio Piomelli?

Sergio Piomelli's AcademicInfluence.com Rankings